Your Article Summary
See Latest ArticlesPlatelet Activating Factor/Platelet Activating Factor Receptor Pathway as a Potential Therapeutic Target in Autoimmune Diseases
Inflammation & Allergy - Drug Targets, 07/02/09
Edwards LJ et al. - Recent experiments from the laboratory show that PAF/PAF-R pathway may influence T cell responses and favour the Th17 phenotype. The PAF/PAF-R pathway is a promising target for pharmacological intervention in autoimmune diseases.
Today in Hematology/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
The Kinase Inhibitors Sunitinib and Sorafenib Differentially Affect NK Cell Antitumor Reactivity In Vitro
Journal of Immunology, 12/16/09
Effects of distant metastasis and peripheral CA 15-3 on the induction of spontaneous T cell responses in breast cancer patients
Cancer Immunology, Immunotherapy, 12/14/09
Today in Rheumatic/Autoimmune...keeping you current
Receive free subspecialty "5-minute updates" via email
A retrospective review of clinical presentation, thyroid autoimmunity, laboratory characteristics, and therapies used in patients with chronic idiopathic urticaria
Annals of Allergy, Asthma, and Immunology, 12/16/09
The Kinase Inhibitors Sunitinib and Sorafenib Differentially Affect NK Cell Antitumor Reactivity In Vitro
Journal of Immunology, 12/16/09
The sympathetic nervous system modulates CD4+FoxP3+ regulatory T cells via a TGF-[beta]-dependent mechanism
Journal of Leukocyte Biology, 12/15/09